A Liposome-Based Nanoparticle Vaccine Induces Effective Immunity Against EBV Infection

A Liposome-Based Nanoparticle Vaccine Induces Effective Immunity Against EBV Infection

<b data-eusoft-scrollable-element="1">Background:</b> Epstein-Barr virus (EBV) infects approximately 95% of the global population, causing numerous malignancy-related cases annually and some autoimmune diseases. EBV-encoded gp350, gH, gL, gp42 and gB glycoproteins are identifie...

Full description

Saved in:
Bibliographic Details
Main Authors: Ping Li, Zihang Yu, Ziyi Jiang, Yike Jiang, Jingjing Shi, Sanyang Han, Lan Ma
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Vaccines
Subjects:
Epstein-Barr virus (EBV)
liposome nanoparticle
vaccine
gp350 glycoprotein
Online Access:https://www.mdpi.com/2076-393X/13/4/360
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2076-393X/13/4/360

Similar Items